Eisai
4523.T
#2011
Rank
S$10.56 B
Marketcap
$37.48
Share price
-0.53%
Change (1 day)
-41.61%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : S$4.42 Billion

According to Eisai's latest financial reports the company's total liabilities are S$4.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31S$4.39 B-15.25%
2022-03-31S$5.18 B17.27%
2021-03-31S$4.42 B-6.68%
2020-03-31S$4.73 B-7.51%
2019-03-31S$5.12 B-4.44%
2018-03-31S$5.36 B0.16%
2017-03-31S$5.35 B12.08%
2016-03-31S$4.77 B-7.79%
2015-03-31S$5.17 B-4.79%
2014-03-31S$5.43 B-19.88%
2013-03-31S$6.78 B-22.98%
2012-03-31S$8.81 B-8.6%
2011-03-31S$9.64 B-5.23%
2010-03-31S$10.17 B-7.43%
2009-03-31S$10.99 B18.86%
2008-03-31S$9.24 B212.94%
2007-03-31S$2.95 B-5.52%
2006-03-31S$3.12 B0.01%
2005-03-31S$3.12 B-0.82%
2004-03-31S$3.15 B3.59%
2003-03-31S$3.04 B17.96%
2002-03-31S$2.58 B-11.54%
2001-03-31S$2.91 B